Navigation For Mobile

Investor Updates

Disclosures

Related Party Disclosure_Half Year ended-(31-03-2022)

Related Party Disclosure_Half Year ended-(31-03-2022)

Secretarial Compliance Report FY 2022

Secretarial Compliance Report FY 2022

Disclosure under Regulation 30 of SEBI_Credit Rating_21 April 2022

Disclosure under Regulation 30 of SEBI_Credit Rating_21 April 2022

Reporting under SEBI (PIT) Regulation, 2015_December 27, 2021

Reporting under SEBI (PIT) Regulation, 2015_December 27, 2021

Disclosure under Regulation 30 of SEBI (LODR)_Demise

Disclosure under Regulation 30 of SEBI (LODR)_Demise

Related Party Disclosure_Half Year ended-(30-09-2021)

Related Party Disclosure_Half Year ended-(30-09-2021)

SE Intimation Credit Rating18 Aug 21

SE Intimation Credit Rating18 Aug 21

Related Party Disclosure_Half Year ended-(31-03-2021)

Related Party Disclosure_Half Year ended-(31-03-2021)

Disclosure under Regulation 30 of SEBI (LODR)_23 April 2021

Disclosure under Regulation 30 of SEBI (LODR)_23 April 2021

Disclosure under Regulation 30 of SEBI_Credit Rating_14 April 2021

Disclosure under Regulation 30 of SEBI_Credit Rating_14 April 2021

Analysts Institutional Investor Meet_31 Dec 2020

Analysts Institutional Investor Meet_31 Dec 2020

Analysts Institutional Investor Meet_25 Nov 2020

Analysts Institutional Investor Meet_25 Nov 2020

Analysts Institutional Investor Meet_18 Nov 2020

Analysts Institutional Investor Meet_18 Nov 2020

Disclosure Under Regulation 30-LODR

Disclosure Under Regulation 30-LODR

Update_ Successful USFDA of Unit 2 (07.05.2020)

Update_ Successful USFDA of Unit 2 (07.05.2020)

Withdrawal of Credit Rating from CARE Ratings Ltd. (28 April 2020)

Withdrawal of Credit Rating from CARE Ratings Ltd. (28 April 2020)

SE Intimation Credit Rating (20 March 2020)

SE Intimation Credit Rating (20 March 2020)

Disclosure Under Regulation 30 of SEBI

Disclosure Under Regulation 30 of SEBI

Successful USFDA Update of Unit 2 (07.02.2020)

Successful USFDA Update of Unit 2 (07.02.2020)

Related Party Disclosure_ Half Year ended- (31-03-2019)

Related Party Disclosure_ Half Year ended- (31-03-2019)

Rating Rationale from CARE Ratings Ltd (02 August 2019)

Rating Rationale from CARE Ratings Ltd (02 August 2019)

Successful USFDA Update of Unit 1 (21-06-2019)

Successful USFDA Update of Unit 1 (21-06-2019)

Disclosure under Regulation 30 of SEBI (Update)

Disclosure under Regulation 30 of SEBI (Update)

Disclosure under Regulation 30 of SEBI

Disclosure under Regulation 30 of SEBI

Rating Rationale from CARE Ratings Ltd

Rating Rationale from CARE Ratings Ltd

Successful USFDA Inspection of Unit 2 (29-11-18)

Successful USFDA Inspection of Unit 2 (29-11-18)

Neuland Acquires New Facility (13-12-17)

Neuland Acquires New Facility (13-12-17)

Update on Purchase of Manufacturing Facility (12-12-17)

Update on Purchase of Manufacturing Facility (12-12-17)

Update on Nanakramguda Project (21-05-17)

Update on Nanakramguda Project (21-05-17)

The Listing Agreement Pertaining to Media Companies and/or their Associates

The Listing Agreement Pertaining to Media Companies and/or their Associates

Draft Letter of Offer (26-03-14)

Draft Letter of Offer (26-03-14)

Letter of Offer (20-03-12)

Letter of Offer (20-03-12)

Contact details for Materiality Disclosure

Contact details for Materiality Disclosure